| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Series C Preferred Stock | 926.3k | $0.00 | $0 | By Domain Partners VII, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Series D Preferred Stock | 435.7k | $0.00 | $0 | By Domain Partners VII, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Series B Preferred Stock | 10.7k | $0.00 | $0 | By DP VII Associates, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Series C Preferred Stock | 15.8k | $0.00 | $0 | By DP VII Associates, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Series D Preferred Stock | 7.4k | $0.00 | $0 | By DP VII Associates, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Series B Preferred Stock | 625.1k | $0.00 | $0 | By Domain Partners VII, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Common Stock | 33.9k | $0.00 | $0 | By DP VII Associates, L.P. | 03/17/2014 |
| 03/17/2014 | Achaogen Inc | AKAO | Conversion | Common Stock | 2M | $0.00 | $0 | By Domain Partners VII, L.P. | 03/17/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Common Stock | 1.8M | $0.00 | $0 | By Domain Partners VIII, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Common Stock | 13k | $0.00 | $0 | By DP VIII Associates, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Series B Preferred Stock | 476.5k | $0.00 | $0 | By Domain Partners VIII, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Series C Preferred Stock | 1.3M | $0.00 | $0 | By Domain Partners VIII, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Warrant | 21k | $0.00 | $0 | By Domain Partners VIII, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Series B Preferred Stock | 3.5k | $0.00 | $0 | By DP VIII Associates, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Series C Preferred Stock | 9.5k | $0.00 | $0 | By DP VIII Associates, L.P. | 02/04/2014 |
| 02/04/2014 | Dicerna Pharmaceuticals Inc | DRNA | Conversion | Warrant | 156 | $0.00 | $0 | By DP VIII Associates, L.P. | 02/04/2014 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Common Stock | 3.1M | $0.00 | $0 | By Domain Partners VIII, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Common Stock | 22.7k | $0.00 | $0 | By DP VIII Associates, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series B Preferred Stock | 2.4M | $0.00 | $0 | By Domain Partners VIII, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series B Preferred Stock | 17.7k | $0.00 | $0 | By DP VIII Associates, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series C Preferred Stock | 681k | $0.00 | $0 | By Domain Partners VIII, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series C Preferred Stock | 5.1k | $0.00 | $0 | By DP VIII Associates, L.P. | 11/04/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Series A Preferred Stock | 19k | $0.00 | $0 | By DP VII Associates, L.P. | 09/30/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Series A Preferred Stock | 1.1M | $0.00 | $0 | By Domain Partners VII, L.P. | 09/30/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Common Stock | 19k | $0.00 | $0 | By DP VII Associates, L.P. | 09/30/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Common Stock | 1.1M | $0.00 | $0 | By Domain Partners VII, L.P. | 09/30/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 395k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 270.6k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 894.1k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 225.9k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Purchase | Common Stock | 750k | $4.00 | $3M | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 4.2k | $0.00 | $0 | By DP VI Associates, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 2.9k | $0.00 | $0 | By DP VI Associates, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 7.4k | $0.00 | $0 | By DP VI Associates, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series B Preferred Stock | 395k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
|